OncoCyte Corporation
NASDAQ:OCX
Overview | Financials
| Company Name | OncoCyte Corporation |
| Symbol | OCX |
| Currency | USD |
| Price | 3.2 |
| Market Cap | 91,517,760 |
| Dividend Yield | 0% |
| 52-week-range | 1.922 - 4.75 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Joshua Riggs |
| Website | https://oncocyte.com |
An error occurred while fetching data.
About OncoCyte Corporation
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD





